TTN
Summary: This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
titin | MIM:188840 | Ensembl:ENSG00000155657 | HGNC:HGNC:12403 | PA37067 | 2q31.2 |
GO terms in TTN
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IPI | GO:0002020 | protease binding |
MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
MF | IDA | GO:0004713 | protein tyrosine kinase activity |
MF | IDA | GO:0005509 | calcium ion binding |
MF | IPI | GO:0005515 | protein binding |
MF | IPI | GO:0005516 | calmodulin binding |
MF | TAS | GO:0005516 | calmodulin binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IBA | GO:0008307 | structural constituent of muscle |
MF | IMP | GO:0008307 | structural constituent of muscle |
MF | TAS | GO:0008307 | structural constituent of muscle |
MF | IPI | GO:0019899 | enzyme binding |
MF | IPI | GO:0019901 | protein kinase binding |
MF | IPI | GO:0031433 | telethonin binding |
MF | ISS | GO:0031433 | telethonin binding |
MF | IPI | GO:0042802 | identical protein binding |
MF | IDA | GO:0042805 | actinin binding |
MF | IPI | GO:0042805 | actinin binding |
MF | IDA | GO:0043621 | protein self-association |
MF | IBA | GO:0051015 | actin filament binding |
MF | IDA | GO:0051015 | actin filament binding |
MF | IBA | GO:0051371 | muscle alpha-actinin binding |
MF | IPI | GO:0051371 | muscle alpha-actinin binding |
MF | TAS | GO:0097493 | structural molecule activity conferring elasticity |
BP | TAS | GO:0002576 | platelet degranulation |
BP | IMP | GO:0003300 | cardiac muscle hypertrophy |
BP | NAS | GO:0006936 | muscle contraction |
BP | TAS | GO:0006936 | muscle contraction |
BP | IBA | GO:0006941 | striated muscle contraction |
BP | TAS | GO:0006941 | striated muscle contraction |
BP | IBA | GO:0007015 | actin filament organization |
BP | IEP | GO:0007076 | mitotic chromosome condensation |
BP | IGI | GO:0010628 | positive regulation of gene expression |
BP | IMP | GO:0010628 | positive regulation of gene expression |
BP | IMP | GO:0010737 | protein kinase A signaling |
BP | IEA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | TAS | GO:0030049 | muscle filament sliding |
BP | IBA | GO:0030240 | skeletal muscle thin filament assembly |
BP | IMP | GO:0030240 | skeletal muscle thin filament assembly |
BP | IBA | GO:0030241 | skeletal muscle myosin thick filament assembly |
BP | IMP | GO:0030241 | skeletal muscle myosin thick filament assembly |
BP | IDA | GO:0035995 | detection of muscle stretch |
BP | TAS | GO:0035995 | detection of muscle stretch |
BP | IBA | GO:0045214 | sarcomere organization |
BP | IMP | GO:0045214 | sarcomere organization |
BP | IMP | GO:0045859 | regulation of protein kinase activity |
BP | IBA | GO:0048739 | cardiac muscle fiber development |
BP | IMP | GO:0048739 | cardiac muscle fiber development |
BP | IMP | GO:0048769 | sarcomerogenesis |
BP | IGI | GO:0050714 | positive regulation of protein secretion |
BP | IMP | GO:0050714 | positive regulation of protein secretion |
BP | IMP | GO:0050790 | regulation of catalytic activity |
BP | IDA | GO:0051592 | response to calcium ion |
BP | IBA | GO:0055003 | cardiac myofibril assembly |
BP | IMP | GO:0055003 | cardiac myofibril assembly |
BP | IBA | GO:0055008 | cardiac muscle tissue morphogenesis |
BP | IMP | GO:0055008 | cardiac muscle tissue morphogenesis |
BP | IMP | GO:0060048 | cardiac muscle contraction |
BP | IBA | GO:0071688 | striated muscle myosin thick filament assembly |
CC | IDA | GO:0000794 | condensed nuclear chromosome |
CC | TAS | GO:0005576 | extracellular region |
CC | TAS | GO:0005829 | cytosol |
CC | IBA | GO:0005859 | muscle myosin complex |
CC | IBA | GO:0005865 | striated muscle thin filament |
CC | IBA | GO:0030018 | Z disc |
CC | IDA | GO:0030018 | Z disc |
CC | IBA | GO:0031430 | M band |
CC | IDA | GO:0031674 | I band |
CC | HDA | GO:0070062 | extracellular exosome |
Gene expression in normal tissue: TTN
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in TTN
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-109582 | Hemostasis |
reactome | R-HSA-114608 | Platelet degranulation |
reactome | R-HSA-390522 | Striated Muscle Contraction |
reactome | R-HSA-397014 | Muscle contraction |
reactome | R-HSA-76002 | Platelet activation, signaling and aggregation |
reactome | R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ |
kegg | hsa05410 | Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) |
kegg | hsa05414 | Dilated cardiomyopathy (DCM) - Homo sapiens (human) |
wikipathways | WP383 | Striated Muscle Contraction |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD1008 | SR-II-138A | 2 |
iGMDRD420 | Leucascandrolide A | 4 |
iGMDRD210 | AC55649 | 1 |
iGMDRD151 | CHM-1 | 4 |
iGMDRD433 | Lexibulin | 4 |
iGMDRD126 | Tipifarnib | 1 |
iGMDRD670 | ML 210 | 4 |
iGMDRD793 | BEC (hydrochloride) | 3 |
iGMDRD61 | Kinetin riboside | 1 |
iGMDRD193 | Fqi1 | 3 |
iGMDRD639 | YK 4-279 | 2 |
iGMDRD201 | SKI II | 2 |
iGMDRD446 | LY 2183240 | 4 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD260 | FQI-2 | 4 |
iGMDRD255 | SB225002 | 4 |
iGMDRD474 | Avrainvillamide | 2 |
iGMDRD138 | PX 12 | 4 |
iGMDRD885 | Compound 110 | 1 |
iGMDRD782 | DC-45-A2 | 4 |
iGMDRD780 | PP-30 | 2 |
iGMDRD577 | BIX01294 | 6 |
iGMDRD730 | Kahalalide F | 3 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD100 | Zebularine | 1 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD524 | ISX-9 | 4 |
iGMDRD23 | Gossypol | 2 |
iGMDRD356 | PNU-74654 | 1 |
iGMDRD64 | Parbendazole | 3 |
iGMDRD60 | Quinoclamine | 1 |
iGMDRD248 | BRD4354 | 1 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD84 | Lovastatin acid | 4 |
iGMDRD79 | Gemcitabine | 1 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD116 | CD437 | 2 |
iGMDRD237 | ABT-751 | 3 |
iGMDRD351 | GW843682X | 2 |
iGMDRD945 | ML214 | 2 |
iGMDRD883 | CIL55A | 3 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD137 | Indisulam | 2 |
iGMDRD121 | GMX1778 | 1 |
iGMDRD103 | SN-38 | 1 |
iGMDRD267 | Oligomycin A | 6 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD289 | Parthenolide | 2 |
iGMDRD329 | Merck60 | 1 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD286 | Nsc 632839 | 4 |
iGMDRD414 | MST-312 | 2 |
iGMDRD246 | NPC26 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in TTN